STAT December 14, 2023
On Wednesday, the Supreme Court announced it will soon weigh in on a case that challenges how the Food and Drug Administration regulates mifepristone, a drug it approved almost 25 years ago that is used to terminate pregnancy.
The case, the Alliance for Hippocratic Medicine v. FDA, is disguised as a dispute over safety. In reality, it’s about whether the courts will go along with overturning, for political reasons, the authority of the FDA as the scientific arbiter of approval of new drugs and restrictions on their distribution.
The Supreme Court must rule in a way that affirms the FDA’s authority.
For nearly a century, federal law has recognized the FDA as the government decision-maker on whether medicines are safe...
Today's Sponsors
Today's Sponsor